about
A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent CohortsThrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients.Nebulised amphotericin B to eradicate Candida colonisation from the respiratory tract in critically ill patients receiving selective digestive decontamination: a cohort studyLong-term outcome of delirium during intensive care unit stay in survivors of critical illness: a prospective cohort study.Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria.The attributable mortality of delirium in critically ill patients: prospective cohort study.Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome.The Impact of HIV Co-Infection on the Genomic Response to Sepsis.Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients.Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: a propensity-matched analysis.Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome.Does ICP monitoring make a difference in neurocritical care?The predictive value of early acute kidney injury for long-term survival and quality of life of critically ill patients.External validation of the APPS, a new and simple outcome prediction score in patients with the acute respiratory distress syndrome.Update on the propofol infusion syndrome in ICU management of patients with head injury.Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review.An Unbalanced Inflammatory Cytokine Response Is Not Associated With Mortality Following Sepsis: A Prospective Cohort Study.Prior Use of Calcium Channel Blockers Is Associated With Decreased Mortality in Critically Ill Patients With Sepsis: A Prospective Observational Study.Impact of HIV infection on the presentation, outcome and host response in patients admitted to the intensive care unit with sepsis; a case control study.Clinical practice of respiratory virus diagnostics in critically ill patients with a suspected pneumonia: A prospective observational study.Transfusion of platelets, but not of red blood cells, is independently associated with nosocomial infections in the critically ill.Epidemiology, Management, and Risk-Adjusted Mortality of ICU-Acquired Enterococcal Bacteremia.Electronic implementation of a novel surveillance paradigm for ventilator-associated events. Feasibility and validation.Long-Term Mental Health Problems After Delirium in the ICU.Multitasking during patient handover in the recovery room.Long-Term Self-Reported Cognitive Problems After Delirium in the Intensive Care Unit and the Effect of Systemic Inflammation.Risk factors, host response and outcome of hypothermic sepsis.Comparative Analysis of the Host Response to Community-acquired and Hospital-acquired Pneumonia in Critically Ill Patients.Admission Hyperglycemia in Critically Ill Sepsis Patients: Association With Outcome and Host Response.Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis.Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients.Cytomegalovirus seroprevalence as a risk factor for poor outcome in acute respiratory distress syndrome*.The propofol infusion syndrome: more puzzling evidence on a complex and poorly characterized disorder.Respiratory syncytial virus in critically ill adult patients with community-acquired respiratory failure: a prospective observational study.Long-term propofol infusion and cardiac failure in adult head-injured patients.Can administrative data be used to consistently measure the burden of sepsis?*.Cerebral oxygen extraction and autoregulation during extracorporeal whole body hyperthermia in humans.Benzodiazepine-associated delirium in critically ill adults.External validation confirms the legitimacy of a new clinical classification of ARDS for predicting outcome.Defining sepsis in the ICU: a sensitivity analysis.
P50
Q28606587-7CE8DA6B-7CDE-49AA-863A-B3A5774071A2Q33430576-30FAF4F2-CF69-42ED-AD24-5427C3E9212EQ33750223-C5100A02-6BDB-4C41-B921-9670C5033CF1Q33892752-AEAAF1EE-8A79-4D73-99A0-8CE15798BE47Q34220502-978D1B0B-FFE3-4108-879B-2A3811B09C47Q34567596-99034DEE-7909-4A83-85B9-3B1F0E3A46C8Q34658350-F127533E-CEE5-40DA-969D-DDB86CFEDD86Q35922190-722B4C44-54A7-4FBF-947F-40E22BA5BAD5Q36317219-C42C7BAB-E26B-45D5-8D0C-D125FF0DD46EQ36564241-B324A118-B149-4278-88BD-8114DF941264Q36564294-12026A98-5E04-4C7E-8D96-5821230792CEQ37090586-943B51E9-2CF2-446A-B0F1-C56312481496Q37150926-656C4710-042C-468B-9B1A-5F1B6A6E6A5AQ37256484-BA2C7854-C5F5-4F93-8265-FEBE16694376Q37265960-9D7ECA10-88F0-4356-B481-76810482F374Q38286758-9A5A9A2C-085A-4026-9191-DA97AC29E03CQ38432917-819FDD9C-55A7-4251-A41B-4CCBE52DDBA5Q38433879-C293453C-189D-4747-83D2-99641730960AQ38435684-E522A5BD-BC6B-4AB8-A35E-AAEAE3212B32Q38436307-601D4560-3AF3-406B-A7E7-0EC137E3B576Q38437038-85DE416B-B5BF-48EF-9651-9644A6BFBC5CQ38442969-DA41443B-F7B5-4F11-BF73-610EE06BCA57Q38450738-6200FAC2-DDCC-4E08-AB9B-9DA28EA081A8Q39500166-767324BC-8D37-4195-B3E1-343D5DE0E86EQ39551773-9B136AB5-BFDE-4064-8F59-B398F9B9A01FQ40276134-5F0E24B3-9E1C-4DB1-89B5-880CC120BE9EQ40507915-46113566-10B4-4339-999B-7630F0E7BDA6Q40643505-01516F75-412A-4EBD-988F-2665591AFCCDQ40762179-A54245DA-689C-43D4-9F92-DA246E39EF90Q40765104-EBE26C19-6276-43D6-8B27-B87DCA21964AQ41650084-AEBE88E5-ABB5-486A-A3A8-EEB0DE2D8D78Q41673437-E115DFD2-4AC9-4272-B024-C75B9809F536Q42115325-41ED4110-4017-4596-9AB9-DDC07E106060Q42248330-4FF70F56-C9A5-48E5-AF30-56FA0448B523Q43528490-D12286C9-F660-4742-B93A-C215AB1AB6B7Q44525927-7B7047EF-AF0D-4473-AA8C-038D4E1879A3Q44869829-96DF6E11-D2FF-4DFE-80D6-ADE11E5D5F4DQ45290249-49CD6493-9F96-4F6C-8763-4AF8482C0C33Q45335721-5F6E3ABE-7839-42C3-8FBB-D1EF73C6B7A8Q46001462-E832491C-82CD-4B33-86C9-3E3B617A64C3
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Olaf L. Cremer
@ast
Olaf L. Cremer
@en
Olaf L. Cremer
@es
Olaf L. Cremer
@nl
Olaf L. Cremer
@sl
type
label
Olaf L. Cremer
@ast
Olaf L. Cremer
@en
Olaf L. Cremer
@es
Olaf L. Cremer
@nl
Olaf L. Cremer
@sl
prefLabel
Olaf L. Cremer
@ast
Olaf L. Cremer
@en
Olaf L. Cremer
@es
Olaf L. Cremer
@nl
Olaf L. Cremer
@sl
P1053
G-3855-2016
P106
P1153
6506120929
P21
P31
P3829
P496
0000-0003-4264-1108